Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice

Neuroscience Research

Volumn 50, Issue 1, 2004, Pages 37-44

  De Sarro, Giovambattista ^a   Ibbadu, Guido Ferreri ^a   Marra, Rosario ^b   Rotiroti, Domenicantonio ^a,b   Loiacono, Antonella ^a   Donato Di Paola, Eugenio ^a   Russo, Emilio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

Aminobutyric acid (GABA); Convulsants; Dystrophin deficient mouse; Epilepsy; Excitatory amino acids; Kindling; mdx; Seizures

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOPYRIDINE; 4 ETHYL 6,7 DIMETHOXY BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; BICUCULLINE; DYSTROPHIN; GLUTAMINE; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; PENTETRAZOLE; PICROTOXIN; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONVULSION; DUCHENNE MUSCULAR DYSTROPHY; EPILEPSY; MOUSE; MOUSE STRAIN; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEIZURE; SEIZURE SUSCEPTIBILITY;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; CONVULSANTS; DISEASE MODELS, ANIMAL; DYSTROPHIN; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GABA ANTAGONISTS; GENETIC PREDISPOSITION TO DISEASE; KINDLING, NEUROLOGIC; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED MDX; PENTYLENETETRAZOLE; POTASSIUM CHANNEL BLOCKERS; REACTION TIME; SPECIES SPECIFICITY; STIMULATION, CHEMICAL;

EID: 3543096964     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2004.05.007     Document Type: Article

References (43)

1. Brenman J.E., Chao D.S., Gee S.H., McGee A.W., Craven S.E., Santillano D.R., Wu L., Huang F., Xia H., Peters M.F., Froehner S.C., Bredt D.S. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDl domain. Cell. 84:1996;757-767
2. Brennan T.J., Seeley W.W., Kilgard M., Schreiner C.E., Tecott L.H. Sound-induced seizures in serotonin 5-HT2C receptor mutant mice. Nat. Genet. 16:1997;387-390
3. Chang W., Lannaccone S.T., Lau K.S., Masters B.S., McCabe T.J., McMillan K., Padre R.C., Spencer M.J., Tidball J.G., Stull J.T. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9142-9147
4. Chapman A.G., De Sarro G.B., Premachandra M., Meldrum B.S. Bidirectional effects of beta-carbolines in reflex epilepsy. Brain Res. Bull. 19:1987;337-346
5. Corda M.G., Orlandi M., Lecca D., Carboni G., Frau V., Giorgi O. Pentylenetetrazol-induced kindling in rats: effect of GABA function inhibitors. Pharmacol. Biochem. Behav. 40:1991;329-333
6. Culligan K.G., Mackey A.J., Finn D.M., Maguire P.B., Ohlendieck K. Role of dystrophin isoforms and associated proteins in muscular dystrophy (review). Int. J. Mol. Med. 2:1998;639-648
7. De Sarro A., Naccari F., De Sarro G. Enhanced susceptibility of pentylenetetrazole kindled mice to quinolone effects. Int. J. Antimicrob. Agents. 12:1999;239-244
8. De Sarro G.B., Meldrum B.S., Nisticò G. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br. J. Pharmacol. 93:1988;247-256
9. De Sarro G., Russo E., Ferreri G., Bruzzese G., Flocco M.A., Donato Di Paola E., De Sarro A. Seizure susceptibility to various convulsant stimuli of knockout interleukin 6 mice. Pharmacol. Biochem. Behav. 77:2004;761-766
10. Echenne B., Rivier F., Jellali A.J., Azais M., Mornet D., Pons F. Merosin positive congenital muscular dystrophy with mental deficiency, epilepsy and MRI changes in the cerebral white matter. Neuromuscul. Disord. 7:1997;187-190
11. 2+ channel physiology and disease etiology. Cell. Mol. Neurobiol. 22:2002;103-120
12. Goodwin F., Muntoni F., Dubowitz V. Epilepsy in Duchenne and Becker muscular dystrophies. Eur. J. Paediatr. Neurol. 1:1997;115-119
13. Kim T.W., Wu K., Xu J.L., Black I.B. Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. U.S.A. 89:1992;11642-11644
14. Knuesel I., Zuellig R.A., Schaub M.C., Fritschy J.M. Alterations in dystrophin and utrophin expression parallel the reorganization of GABAergic synapses in a mouse model of temporal lobe epilepsy. Eur. J. Neurosci. 13:2001;1113-1124
15. Lidov H.G., Byers T.J., Watkins S.C., Kunkel L.M. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature. 348:1990;725-728
16. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113
17. Malas S., Postlethwaite M., Ekonomou A., Whalley B., Nishiguchi S., Wood H., Meldrum B., Constanti A., Piskopou V. Sox1-deficient mice suffer from epilepsy associated with abnormal ventral forebrain development and olfactory cortex hyperexcitability. Neuroscience. 119:2003;421-432
18. Manni R., Ottolini A., Cerveri I., Bruschi C., Zoia M.C., Lanzi G., Tartara A. Breathing patterns and HbSaO2 changes during nocturnal sleep in patients with Duchenne muscular dystrophy. J. Neurol. 236:1989;391-394
19. McNamara, J.O., Bonhaus, D.W., Crain, B.J., Gellman, R.L., Shin, C., Biochemical and pharmacological studies of neurotransmitters in the kindling model. In: Jobe, P.C., Laird II, H.E. (Eds.), 1989. Neurotransmitters and Epilepsy. Humana Press, Clifton, NJ, pp. 115-160.
20. Medori R., Brooke M.H., Waterston R.H. Genetic abnormalities in Duchenne and Becker dystrophies: clinical correlations. Neurology. 39:1989;461-465
21. Mehler M.F. Brain dystrophin, neurogenetics and mental retardation. Brain Res. Rev. 32:2000;277-307
22. Mehler M.F., Haas K.Z., Kessler J.A., Stanton P.K. Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission. Proc. Natl. Acad. Sci. U.S.A. 89:1992;2461-2465
23. Miike T., Sugino S., Ohtani Y., Taku K., Yoshioka K. Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage. J. Neurol. Sci. 82:1987;67-80
24. Misawa H., Sherr E.H., Lee D.J., Chetkovich D.M., Tan A., Schreiner C.E., Bredt D.S. Identification of a monogenic locus (jams1) causing juvenile audiogenic seizures in mice. J. Neurosci. 22:2002;10088-10093
25. Moukhles H., Carbonetto S. Dystroglycan contributes to the formation of multiple dystrophin-like complexes in brain. J. Neurochem. 78:2001;824-834
26. Musumeci S.A., Bosco P., Calabrese G., Bakker C., De Sarro G.B., Elia M., Ferri R., Oostra B.A. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia. 41:2000;19-23
27. Neumann P.E., Collins R.L. Genetic dissection of susceptibility to audiogenic seizures in inbred mice. Proc. Natl. Acad. Sci. U.S.A. 88:1991;5408-5412
28. Neumann P.E., Seyfried T.N. Mapping of two genes that influence susceptibility to audiogenic seizures in crosses of C57BL/6J and DBA/2J mice. Behav. Genet. 20:1990;307-323
29. Noebels J.L. A single gene error of noradrenergic axon growth synchronizes central neurones. Nature. 310:1984;409-411
30. Noebels J.L. Exploring new gene discoveries in idiopathic generalized epilepsy. Epilepsia. 44:2003;16-21
31. Owens D.F., Kriegstein A.R. Is there more to GABA than synaptic inhibition? Nat. Rev. Neurosci. 3:2002;715-727
32. Reed U.C., Marie S.K., Vainzof M., Gobbo L.F., Gurgel J.E., Carvalho M.S., Resende M.B., Espindola A.A., Zatz M., Diament A. Heterogeneity of classic congenital muscular dystrophy with involvement of the central nervous system: report of five atypical cases. J. Child Neurol. 15:2000;172-178
33. Rise M.L., Frankel W.N., Coffin J.M., Seyfried T.N. Genes for epilepsy mapped in the mouse. Science. 253:1991;669-673
34. Rosman N.P., Kakulas B.A. Mental deficiency associated with muscular dystrophy. A neuropathological study. Brain. 89:1966;769-788
35. SAS Institute Inc, 1987. SAS/STAT Guide for Personal Computers, version 6 edition. SAS Institute Inc. Cary, NC, U.S.A.
36. Schmitz D., Mellor J., Frerking M., Nicoll R.A. Presynaptic kainate receptors at hippocampal mossy fiber synapses. Proc. Natl. Acad. Sci. U.S.A. 98:2001;11003-11008
37. Seyfried T.N., Glaser G.H. A review of mouse mutants as genetic models of epilepsy. Epilepsia. 26:1985;143-150
38. Smith P.E., Calverley P.M., Edwards R.H. Hypoxemia during sleep in Duchenne muscular dystrophy. Am. Rev. Respir. Dis. 137:1988;884-888
39. Swinyard, E.A., Woodhead, J.M., 1982. Experimental detection, quantification and evaluation of anticonvulsants. In: Woodbury, D.M., Penry, J.K., Pippinger, C.E. (Eds.), Antipileptic Drugs. Raven Press, New York, pp. 111-126.
40. Takumi Y., Matsubara A., Rinvik E., Ottersen O.P. The arrangement of glutamate receptors in excitatory synapses. Ann. N. Y. Acad. Sci. 868:1999;474-482
41. Upton N., Stratton S. Recent developments from genetic mouse models of seizures. Curr. Opin. Pharmacol. 3:2003;19-26
42. Yamaguchi S., Rogawski M.A. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res. 11:1992;9-16
43. Yoshihara Y., Onodera H., Iinuma K., Itoyama Y. Abnormal kainic acid receptor density and reduced seizure susceptibility in dystrophin deficient mdx mice. Neuroscience. 117:2003;391-395